Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

AJAY K NOOKA

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1801000260
CMS profile
172719
Location
ATLANTA, GA

General Payments · PY2018–2024

$210,999.78

  • Reported across 161 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$42,640.39

32 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Janssen Research & Development, LLC $13,778.65 4
Janssen Biotech, Inc. $7,175.42 16
GlaxoSmithKline, LLC. $6,000.00 2
GENZYME CORPORATION $5,708.00 3
PFIZER INC. $4,203.32 3
Janssen Global Services, LLC $3,720.00 3
AstraZeneca UK Limited $2,055.00 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $27,061.08 31
PY2019 $37,399.59 23
PY2020 $10,436.00 4
PY2021 $30,909.92 8
PY2022 $30,323.77 25
PY2023 $32,229.03 38
PY2024 $42,640.39 32

Payment records · PY2024 (32)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca UK Limited $2,055.00 10/23/2024 Consulting Fee Undisputed 01/23/2026 1093928557 CMS
GENZYME CORPORATION $270.07 07/11/2024 Travel and Lodging Undisputed 01/23/2026 1139787421 CMS
GENZYME CORPORATION $437.93 07/11/2024 Travel and Lodging Undisputed 01/23/2026 1139787423 CMS
GENZYME CORPORATION $5,000.00 07/11/2024 Consulting Fee Undisputed 01/23/2026 1139787425 CMS
GlaxoSmithKline, LLC. $2,800.00 06/21/2024 Consulting Fee Undisputed 01/23/2026 1116194181 CMS
GlaxoSmithKline, LLC. $3,200.00 07/08/2024 Consulting Fee Undisputed 01/23/2026 1116206123 CMS
Janssen Biotech, Inc. $29.94 02/27/2024 Food and Beverage Undisputed 01/23/2026 1078526479 CMS
Janssen Biotech, Inc. $27.78 02/27/2024 Food and Beverage Undisputed 01/23/2026 1078527681 CMS
Janssen Biotech, Inc. $49.27 03/02/2024 Food and Beverage Undisputed 01/23/2026 1078524320 CMS
Janssen Biotech, Inc. $26.20 03/22/2024 Food and Beverage Undisputed 01/23/2026 1078527752 CMS
Janssen Biotech, Inc. $142.85 07/24/2024 Food and Beverage Undisputed 01/23/2026 1078525334 CMS
Janssen Biotech, Inc. $605.64 07/24/2024 Travel and Lodging Undisputed 01/23/2026 1078525734 CMS
Janssen Biotech, Inc. $19.04 07/24/2024 Food and Beverage Undisputed 01/23/2026 1078528040 CMS
Janssen Biotech, Inc. $22.39 07/26/2024 Food and Beverage Undisputed 01/23/2026 1078526228 CMS
Janssen Biotech, Inc. $22.59 09/24/2024 Food and Beverage Undisputed 01/23/2026 1078524548 CMS
Janssen Biotech, Inc. $12.79 09/24/2024 Food and Beverage Undisputed 01/23/2026 1078526260 CMS
Janssen Biotech, Inc. $36.80 09/25/2024 Food and Beverage Undisputed 01/23/2026 1078524028 CMS
Janssen Biotech, Inc. $1,559.25 10/08/2024 Consulting Fee Undisputed 01/23/2026 1078843829 CMS
Janssen Biotech, Inc. $803.25 10/08/2024 Consulting Fee Undisputed 01/23/2026 1078843831 CMS
Janssen Biotech, Inc. $150.00 10/18/2024 Food and Beverage Undisputed 01/23/2026 1078522250 CMS
Janssen Biotech, Inc. $67.63 12/07/2024 Food and Beverage Undisputed 01/23/2026 1078527401 CMS
Janssen Biotech, Inc. $3,600.00 12/19/2024 Consulting Fee Undisputed 01/23/2026 1078525155 CMS
Janssen Global Services, LLC $1,550.00 01/10/2024 Consulting Fee Undisputed 01/23/2026 1077590833 CMS
Janssen Global Services, LLC $930.00 07/15/2024 Consulting Fee Undisputed 01/23/2026 1077590837 CMS
Janssen Global Services, LLC $1,240.00 07/18/2024 Consulting Fee Undisputed 01/23/2026 1077590831 CMS
Janssen Research & Development, LLC $12,400.00 01/01/2024 Consulting Fee Undisputed 01/23/2026 1077590303 CMS
Janssen Research & Development, LLC $83.65 04/10/2024 Food and Beverage Undisputed 01/23/2026 1077587821 CMS
Janssen Research & Development, LLC $675.00 07/01/2024 Consulting Fee Undisputed 01/23/2026 1077590307 CMS
Janssen Research & Development, LLC $620.00 09/09/2024 Consulting Fee Undisputed 01/23/2026 1077590305 CMS
PFIZER INC. $2,260.00 01/03/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1131561124 CMS
PFIZER INC. $53.32 07/26/2024 Food and Beverage Undisputed 01/23/2026 1131796980 CMS
PFIZER INC. $1,890.00 12/10/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1131233393 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.